There was also a -3.75-fold significant decrease in GLB1, a-galactosidase involved in the different types of protein glycosylation and in the processing of gangliosides, more specifically GM1, which is reported to be reduced in PD brains (22) (Fig. 4). This evidence concerns the gene GLB1 and Parkinson disease.